Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

2.550
+0.0301.19%
Volume:69.20K
Turnover:176.95K
Market Cap:1.96B
PE:15.55
High:2.580
Open:2.540
Low:2.520
Close:2.520
52wk High:3.319
52wk Low:1.959
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.72
T/O Rate:0.02%
Dividend:0.72
Dividend Rate:28.07%
EPS(TTM):0.164
EPS(LYR):2.770
ROE:11.28%
ROA:5.13%
PB:2.21
PE(LYR):0.92

Loading ...

Tianjin Pharmaceutical Da Ren Tang gains China approval for two Loxoprofen Sodium Patch products

SGX Filings
·
Yesterday

Tianjin Pharmaceutical Da Ren Tang reports no new developments in subsidiary bankruptcy case

SGX Filings
·
Sep 29

Tianjin Pharmaceutical Da Ren Tang Provides Update on Planned Upstream Share Transfer

SGX Filings
·
Sep 24

Tianjin Pharmaceutical Da Ren Tang Proposes Articles Amendments to Broaden Business Scope

SGX Filings
·
Sep 04

Tianjin Pharmaceutical Da Ren Tang Group issues August update on subsidiary’s bankruptcy process

SGX Filings
·
Aug 31

Tianjin Pharmaceutical Da Ren Tang shareholders approve remuneration policy and 2026 directors’ pay

SGX Filings
·
Aug 28

Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on Interim Results

SGX Filings
·
Aug 26

Tianjin Pharmaceutical Da Ren Tang reports status of placement proceeds and project changes

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang Proposes Amendments to Articles of Association

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Da Ren Tang releases H1 2026 risk assessment on in-house finance arm

SGX Filings
·
Aug 14

Tianjin Pharmaceutical Unit Gets China's Nod for Diabetes Drug Registration

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang to Sign Warehousing Deal

MT Newswires
·
Aug 10

Tianjin Pharmaceutical Da Ren Tang receives Chinese approval for diabetes combo tablets

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang to Ink S$3.6 Million Related-Party Logistics Deal

SGX Filings
·
Aug 07

Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%

SGX Filings
·
Aug 04

Tianjin Pharmaceutical Da Ren Tang Group Issues July Update on Subsidiary Bankruptcy

SGX Filings
·
Jul 31

Tianjin Pharmaceuticals Warns of Up to 68% Plunge in H1 Profit

MT Newswires Live
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang projects steep profit fall for 1H FY2026

SGX Filings
·
Jul 14

Tianjin Pharmaceutical Da Ren Tang updates on subsidiary’s bankruptcy liquidation

SGX Filings
·
Jun 30

Tianjin Pharmaceutical Da Ren Tang Group Approves FY2025 Reports, Profit Distribution and IPT Mandates at AGM

SGX Filings
·
Jun 03